Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Cimpress plc - Ordinary Shares
Sportradar Group AG - Class A Ordinary Shares
Edit Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
iShares ESG Aware MSCI USA Small-Cap ETF
(NY:
ESML
)
49.89
-1.34 (-2.62%)
Official Closing Price
Updated: 8:00 PM EST, Nov 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about iShares ESG Aware MSCI USA Small-Cap ETF
MLTX Stock Gains As Retail Eyes Buyout From Big Pharma, Upcoming Investor Day Event
↗
February 17, 2026
Some Stocktwits users voiced optimism for the inflammation-drug maker getting acquired by pharma giant Merck.
Via
Stocktwits
Topics
Intellectual Property
Stanich Group Sells $5 Million of iShares ESG Aware USD Corporate Bond ETF
↗
February 02, 2026
iShares ESG Aware USD Corporate Bond ETF offers exposure to investment-grade bonds with an ESG focus and a disciplined, passive strategy.
Via
The Motley Fool
Topics
Bonds
Derivatives
ETFs
MLTX Stock Extends Rally As FDA Feedback Spurs Bullish Brokerage Action – Retail Speculates On Potential M&A Conversations
↗
January 09, 2026
Via
Stocktwits
Why Did MLTX Stock Jump 45% In Pre-Market Today?
↗
January 08, 2026
The company said it received positive regulatory feedback from the U.S. FDA following a Type B meeting regarding a drug used to treat hidradenitis suppurativa, a chronic inflammatory skin disorder.
Via
Stocktwits
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1